Midatech Pharma’s £10-Million Share Placing

Brown Rudnick LLP advised Midatech Pharma PLC on the deal.

Midatech Pharma PLC raised £10 million through a placing to investors in the United Kingdom of approximately 35 million ordinary shares in the capital of the company.

Midatech is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. Dual listed on AIM and NASDAQ, Midatech will use the proceeds from the placing to develop additional monoclonal-antibody formulations its Q-Sphera technology, add new small-molecule Q-Sphera programs to its pipeline, and start clinical studies.

The Brown Rudnick team included Lena Hodge (Picture), Nick Davies, Mark Lubbock, Jason McCaffrey, and Tobias Plowman.

Involved fees earner: Nick Davies – Brown Rudnick LLP; Lena Hodge – Brown Rudnick LLP; Mark Lubbock – Brown Rudnick LLP; Jason McCaffrey – Brown Rudnick LLP; Tobias Plowman – Brown Rudnick LLP;

Law Firms: Brown Rudnick LLP;

Clients: Midatech Pharma;

Federica Tiefenthaler

Author: Federica Tiefenthaler